SOLICITATION NOTICE
A -- NONHUMAN PRIMATE CORE QUANTITATIVE VIRAL RNA LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
- Notice Date
- 2/26/2010
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700 B Rockledge Room 3214 MSC7612, Bethesda, Maryland, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- RFP-NIAID-DAIDS-NIHAI2009073
- Point of Contact
- Cassandra Ellis, Phone: 301-451-3691, Anita Hughes, Phone: 301-496-0612
- E-Mail Address
-
ellisca@niaid.nih.gov, anhughes@niaid.nih.gov
(ellisca@niaid.nih.gov, anhughes@niaid.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- NIAID/DAIDS NONHUMAN PRIMATE QUANTITATIVE VIRAL RNA LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT RFP: NIAID-DAIDS-NIHAI2009073 Type of Requirement Re-competition (Contract No.: N01-AI-30057) Advanced BioScience Laboratories, Inc. 5510 Nicholson Lane Kensington, MD 20895 Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700-B Rockledge Drive, Room 3214, MSC 7612, Bethesda, MD, 20892-7612 Anticipated Period of Performance The period of performance will be for one year with options for continued performance for an additional six years, for a total period of performance of seven years. Anticipated award date: March 30, 2011 The NAICS Code is 541712 with a size standard of 500 employees Presolicitation Notice Information The NIAID provides immunological and virological support for nonhuman primate studies conducted at NIAID's Simian Vaccine Evaluation Unit contract sites (SVEUs) and by AIDS vaccine researchers through three Nonhuman Primate Immunology and Virology Laboratories for AIDS Vaccine Research and Development, previously called the NHP "Core Laboratories." The objective of the Core Laboratories has been to insure standardization and comparability of the assays conducted for preclinical NHP studies and to provide a common basis for assessment of the immunogenicity and efficacy of candidate HIV and SIV vaccines. The current contract for this work Contract No. N01-AI-30057, is entitled "Primate Core Immunology - Virology Laboratories, Part C: Quantitative Viral RNA Laboratory" with Advanced BioScience Laboratories, Inc. The purpose of the proposed contract is to provide a nonhuman primate virology laboratory that will conduct quantitative viral RNA measurements in support of studies that evaluate prototype AIDS vaccines in nonhuman primates. The contract will support the conduct, improvement, and development of assays designed to measure viral RNA loads in nonhuman primates that have been immunized with candidate HIV or SIV vaccines and challenged with SIV or SHIV in studies conducted at DAIDS Simian Vaccine Evaluation Unit contract sites or by NIH-supported investigators. The Contractor shall use state-of the-art technologies to accomplish the contract objectives and shall incorporate new and improved technologies into contract activities when appropriate. The Contractor shall focus on the development, optimization, and conduct of assays to detect and assess antiviral neutralizing antibodies from immunized and infected animals. The Contractor shall use GLP processes to conduct assays when assessing humoral immune responses in NHP studies conducted with human clinical candidate AIDS vaccines. It is anticipated that one cost reimbursement, term type contract will be awarded for a 1-year Base period plus six 1-year options for a possible total period of performance of 7 years beginning on or about March 30, 2011. The performance requirement will be for the delivery of 2.04 full time equivalents (FTEs) per year for the base period (Year 1) and option periods (Years 2 through 7), which may be unilaterally exercised by the Government. In addition, the Government may exercise options to accommodate significant increases in work to be provided for the base period and option periods. Should the Government elect to exercise an option for increased level of effort, the Contractor shall provide resources for the unanticipated increase in work volume for.35 additional FTEs for each option exercised. The Government may exercise an option up to three times in any year of the contract. Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on/about March 17, 2010, and may be accessed through the NIAID Office of Acquisitions (OA) Home Page at http://www.niaid.nih.gov/contract and through FedBizOpps http://www.fedbizopps.gov/. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAID-DAIDS-NIHAI2009073/listing.html)
- Place of Performance
- Address: Place of performance is unknown at this time, United States
- Record
- SN02078215-W 20100228/100227000031-3756195a5f8c2d58abd3ea363183db95 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |